Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Low Midlife PSA Linked to Reduced 20-Year Prostate Cancer Risk
February 2026
A 20-year cohort study shows men with low baseline PSA face minimal prostate cancer risk, supporting personalised screening strategies using PSA and PSA density.
Read more
6 Jan 2025
Dual Roles of Androgen Receptor in Prostate Cancer
Recent research has unveiled the crucial role of Androgen Response Elements in governing androgen receptors growth-suppressive transcriptional programs.
4 Jan 2025
Metformin Does Not Affect Prostate Cancer Progression Rates
Despite promising preclinical and epidemiological data, metformin does not appear to impact disease progression in men with low-risk prostate cancer.
1 Jan 2025
Enhancing Prostate Cancer Detection in Diverse Populations
Stockholm3 demonstrates significant potential to enhance prostate cancer detection in diverse populations while maintaining similar sensitivity to PSA.
30 Dec 2024
Advancing Prostate Cancer Care with Biomarker-Driven Insights
The study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC, particularly for select subgroups with favourable biomarkers.
29 Dec 2024
Baduanjin Exercise: A Promising Solution for Prostate Cancer Fatigue
Baduanjin consists of eight simple, flowing movements focusing on deep breathing, muscle relaxation, and mindful awareness.
23 Dec 2024
Long-Term Benefits of MRI-Guided Stereotactic Body Radiotherapy
Logistic regression analysis revealed that patients receiving MRI-guided stereotactic body radiotherapy had significantly lower odds of experiencing clinically relevant deterioration.
21 Dec 2024
High Omega-3 Diet Lowers Key Prostate Cancer Marker
Results demonstrated that the Ki-67 index decreased in the low omega-6 fatty acid diet supplemented with fish oil capsules group by approximately 15% from baseline to one year.
19 Dec 2024
Prostate Cancer Screening Disparities in Ireland
The introduction of rapid access prostate clinics aimed to streamline referrals and improve diagnosis.
Loading posts...
« Previous
1
…
23
24
25
26
27
…
45
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View